MoneyWorks4Me

Pfizer - Quaterly Results

09 Feb 2023 Evaluate
Net sales declined -8.01%  to  Rs. 6217.50 million from Rs. 6759.00 millions.Net profit showed a marginal rise at Rs. 1506.60 millions for the quarter ended December 2022, as compared to corresponding quarter of last year.Operating profit surged to 2308.60 millions from the corresponding previous quarter of 2134.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 6217.50 6759.00 -8.01 18521.20 20613.30 -10.15 26109.90 22385.50 16.64
Other Income 274.10 182.60 50.11 696.70 455.30 53.02 626.50 811.20 -22.77
PBIDT 2308.60 2134.30 8.17 6966.60 7158.10 -2.68 8983.80 7932.40 13.25
Interest 38.40 21.80 76.15 108.60 66.40 63.55 104.90 151.10 -30.58
PBDT 2270.20 2112.50 7.47 7383.90 7091.70 4.12 8878.90 7781.30 14.11
Depreciation 263.40 271.60 -3.02 791.00 813.90 -2.81 1150.00 1094.10 5.11
PBT 2006.80 1840.90 9.01 6592.90 6277.80 5.02 7728.90 6687.20 15.58
TAX 500.20 401.80 24.49 1650.10 1410.10 17.02 1603.30 1711.10 -6.30
Deferred Tax -17.80 -146.70 -87.87 -203.80 -263.90 -22.77 -359.30 -125.20 186.98
PAT 1506.60 1439.10 4.69 4942.80 4867.70 1.54 6125.60 4976.10 23.10
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 37.13 31.58 17.59 37.61 34.73 8.32 34.41 35.44 -2.90
Peers
Company Name CMP
Sun Pharma. Inds. 1850.80
Dr. Reddys Labs. 1216.60
Cipla 1382.10
Lupin 2101.00
Zydus Lifesciences 1171.95
View more..